17-5: Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma
Audible Article by Averill Guo, Sydney Pomenti, and Julia Wattacheril
17-4: Bariatric Surgery in the Peritransplant Period
Audible Article by Sydney Pomenti, Sanket Mehta, Averill Guo, and Julia Wattacheril
Suffering, Healing, and Meaning, with Philip Yancey and Julia Wattacheril
On Friday, April 23rd, 2021 we were delighted to launch a new series on “Discovery and Doxology” in partnership with BioLogos and Church of the Advent. This series brings together leading scientists and theologians to discuss the relationship between science and faith. In this, our first event in t…
Medicine in 2020: Healing Moral Injuries | Julia Wattacheril
As a follow-up to her 2017 workshop “Survive or Thrive: Transformation is Possible, Even in Healthcare,” Dr. Wattacheril will provide a framework for exploring the moral injury associated with working in healthcare. Join her to discuss helpful spiritual tools for resilience and growth within and be…
100. May Hope Abound
N.T. Wright, Francis Collins, John Walton, Deb Haarsma, Julia Wattacheril, Charlotte vanOyen-Witvliet, and Curtis Chang come back to the podcast to share their wisdom about hope.
Jim Stump's article on hope
Deb Haarsma's article on hope
Arthur Brooks Atlantic article on Hope and Optimism
N.T. Wri…
The Updated Role of Non-Invasive Biomarkers in MASLD
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Julia J Wattacheril, MD, MPH
Non-invasive biomarkers for metabolic dysfunction-associated steatosis liver disease (MASLD) are used to stratify risk and assess disease severity in our patients. In this episode, Dr. Peter Buch is joined by …
#302 - Confronting a metabolic epidemic: understanding liver health and how to prevent, diagnose, and manage liver disease | Julia Wattacheril, M.D., M.P.H.
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
Julia Wattacheril is a physician scientist and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Ir…
#319 ‒ Peter's key takeaways on liver health, heart rate variability, AI in medicine, klotho, and lactate metabolism | Quarterly Podcast Summary #2
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this quarterly podcast summary (QPS) episode, Peter summarizes his biggest takeaways from the last three months of guest interviews on the podcast. Peter shar…
How is liver disease diagnosed?
Learn about common misconceptions and the pathway that you might experience to investigate and evaluate your liver's health with your health care team. Our host, Jeff McIntyre, is joined by Dr. Julia Wattacheril, MASLD Director at Columbia NewYork-Presbyterian Hospital and expert clinician and rese…
The Updated Role of Non-Invasive Biomarkers in MASLD
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Julia J Wattacheril, MD, MPH
Non-invasive biomarkers for metabolic dysfunction-associated steatosis liver disease (MASLD) are used to stratify risk and assess disease severity in our patients. In this episode, Dr. Peter Buch is joined by …
ポッドキャスト検索エンジン
当社の Web サイトを使用して、人、場所、トピックごとに 3,834,470 ポッドキャストや 197,263,118 エピソードを検索できます。
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
